{"id":32988,"date":"2025-07-30T08:48:54","date_gmt":"2025-07-30T08:48:54","guid":{"rendered":"https:\/\/ibima.eu\/estudio-prospectivo-de-24-meses-multicentrico-no-intervencional-para-evaluar-la-efectividad-de-elocta-en-comparacion-con-productos-del-factor-convencional-en-el-tratamiento-profilactico-de-pacientes\/"},"modified":"2025-07-30T08:48:54","modified_gmt":"2025-07-30T08:48:54","slug":"estudio-prospectivo-de-24-meses-multicentrico-no-intervencional-para-evaluar-la-efectividad-de-elocta-en-comparacion-con-productos-del-factor-convencional-en-el-tratamiento-profilactico-de-pacientes","status":"publish","type":"post","link":"https:\/\/ibima.eu\/en\/estudio-prospectivo-de-24-meses-multicentrico-no-intervencional-para-evaluar-la-efectividad-de-elocta-en-comparacion-con-productos-del-factor-convencional-en-el-tratamiento-profilactico-de-pacientes\/","title":{"rendered":"Estudio prospectivo de 24 meses, multic\u00e9ntrico, no intervencional para evaluar la efectividad de Elocta en comparaci\u00f3n con productos del factor convencional en el tratamiento profil\u00e1ctico de pacientes con hemofilia A. (Sobi.Elocta-002)"},"content":{"rendered":"<p>FRANCISCO JOSE LOPEZ JAIME &#8211; ESTUDIO POSAUTORIZACION COMERCIAL &#8211; No aplica &#8211; SWEDISH ORPHAN BIOVITRUM AB<\/p>","protected":false},"excerpt":{"rendered":"<p>FRANCISCO JOSE LOPEZ JAIME &#8211; ESTUDIO POSAUTORIZACION COMERCIAL &#8211; No aplica &#8211; SWEDISH ORPHAN BIOVITRUM AB<\/p>","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[2263,2901],"tags":[],"class_list":["post-32988","post","type-post","status-publish","format-standard","hentry","category-ensayos-clinicos","category-ensayos-clinicos-be-03"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Estudio prospectivo de 24 meses, multic\u00e9ntrico, no intervencional para evaluar la efectividad de Elocta en comparaci\u00f3n con productos del factor convencional en el tratamiento profil\u00e1ctico de pacientes con hemofilia A. (Sobi.Elocta-002) - Ibima<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ibima.eu\/en\/estudio-prospectivo-de-24-meses-multicentrico-no-intervencional-para-evaluar-la-efectividad-de-elocta-en-comparacion-con-productos-del-factor-convencional-en-el-tratamiento-profilactico-de-pacientes\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Estudio prospectivo de 24 meses, multic\u00e9ntrico, no intervencional para evaluar la efectividad de Elocta en comparaci\u00f3n con productos del factor convencional en el tratamiento profil\u00e1ctico de pacientes con hemofilia A. (Sobi.Elocta-002) - Ibima\" \/>\n<meta property=\"og:description\" content=\"FRANCISCO JOSE LOPEZ JAIME &#8211; ESTUDIO POSAUTORIZACION COMERCIAL &#8211; No aplica &#8211; SWEDISH ORPHAN BIOVITRUM AB\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ibima.eu\/en\/estudio-prospectivo-de-24-meses-multicentrico-no-intervencional-para-evaluar-la-efectividad-de-elocta-en-comparacion-con-productos-del-factor-convencional-en-el-tratamiento-profilactico-de-pacientes\/\" \/>\n<meta property=\"og:site_name\" content=\"Ibima\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-30T08:48:54+00:00\" \/>\n<meta name=\"author\" content=\"prodriguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"prodriguez\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/estudio-prospectivo-de-24-meses-multicentrico-no-intervencional-para-evaluar-la-efectividad-de-elocta-en-comparacion-con-productos-del-factor-convencional-en-el-tratamiento-profilactico-de-pacientes\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/estudio-prospectivo-de-24-meses-multicentrico-no-intervencional-para-evaluar-la-efectividad-de-elocta-en-comparacion-con-productos-del-factor-convencional-en-el-tratamiento-profilactico-de-pacientes\\\/\"},\"author\":{\"name\":\"prodriguez\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\"},\"headline\":\"Estudio prospectivo de 24 meses, multic\u00e9ntrico, no intervencional para evaluar la efectividad de Elocta en comparaci\u00f3n con productos del factor convencional en el tratamiento profil\u00e1ctico de pacientes con hemofilia A. (Sobi.Elocta-002)\",\"datePublished\":\"2025-07-30T08:48:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/estudio-prospectivo-de-24-meses-multicentrico-no-intervencional-para-evaluar-la-efectividad-de-elocta-en-comparacion-con-productos-del-factor-convencional-en-el-tratamiento-profilactico-de-pacientes\\\/\"},\"wordCount\":50,\"commentCount\":0,\"articleSection\":[\"Ensayos Cl\u00ednicos\",\"Ensayos Cl\u00ednicos - BE-03\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/ibima.eu\\\/estudio-prospectivo-de-24-meses-multicentrico-no-intervencional-para-evaluar-la-efectividad-de-elocta-en-comparacion-con-productos-del-factor-convencional-en-el-tratamiento-profilactico-de-pacientes\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/estudio-prospectivo-de-24-meses-multicentrico-no-intervencional-para-evaluar-la-efectividad-de-elocta-en-comparacion-con-productos-del-factor-convencional-en-el-tratamiento-profilactico-de-pacientes\\\/\",\"url\":\"https:\\\/\\\/ibima.eu\\\/estudio-prospectivo-de-24-meses-multicentrico-no-intervencional-para-evaluar-la-efectividad-de-elocta-en-comparacion-con-productos-del-factor-convencional-en-el-tratamiento-profilactico-de-pacientes\\\/\",\"name\":\"Estudio prospectivo de 24 meses, multic\u00e9ntrico, no intervencional para evaluar la efectividad de Elocta en comparaci\u00f3n con productos del factor convencional en el tratamiento profil\u00e1ctico de pacientes con hemofilia A. (Sobi.Elocta-002) - Ibima\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\"},\"datePublished\":\"2025-07-30T08:48:54+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/estudio-prospectivo-de-24-meses-multicentrico-no-intervencional-para-evaluar-la-efectividad-de-elocta-en-comparacion-con-productos-del-factor-convencional-en-el-tratamiento-profilactico-de-pacientes\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ibima.eu\\\/estudio-prospectivo-de-24-meses-multicentrico-no-intervencional-para-evaluar-la-efectividad-de-elocta-en-comparacion-con-productos-del-factor-convencional-en-el-tratamiento-profilactico-de-pacientes\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/estudio-prospectivo-de-24-meses-multicentrico-no-intervencional-para-evaluar-la-efectividad-de-elocta-en-comparacion-con-productos-del-factor-convencional-en-el-tratamiento-profilactico-de-pacientes\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Estudio prospectivo de 24 meses, multic\u00e9ntrico, no intervencional para evaluar la efectividad de Elocta en comparaci\u00f3n con productos del factor convencional en el tratamiento profil\u00e1ctico de pacientes con hemofilia A. (Sobi.Elocta-002)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\",\"name\":\"Ibima\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ibima.eu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\",\"name\":\"prodriguez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"caption\":\"prodriguez\"},\"sameAs\":[\"https:\\\/\\\/ibima.eu\"],\"url\":\"https:\\\/\\\/ibima.eu\\\/en\\\/author\\\/prodriguez\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Estudio prospectivo de 24 meses, multic\u00e9ntrico, no intervencional para evaluar la efectividad de Elocta en comparaci\u00f3n con productos del factor convencional en el tratamiento profil\u00e1ctico de pacientes con hemofilia A. (Sobi.Elocta-002) - Ibima","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ibima.eu\/en\/estudio-prospectivo-de-24-meses-multicentrico-no-intervencional-para-evaluar-la-efectividad-de-elocta-en-comparacion-con-productos-del-factor-convencional-en-el-tratamiento-profilactico-de-pacientes\/","og_locale":"en_GB","og_type":"article","og_title":"Estudio prospectivo de 24 meses, multic\u00e9ntrico, no intervencional para evaluar la efectividad de Elocta en comparaci\u00f3n con productos del factor convencional en el tratamiento profil\u00e1ctico de pacientes con hemofilia A. (Sobi.Elocta-002) - Ibima","og_description":"FRANCISCO JOSE LOPEZ JAIME &#8211; ESTUDIO POSAUTORIZACION COMERCIAL &#8211; No aplica &#8211; SWEDISH ORPHAN BIOVITRUM AB","og_url":"https:\/\/ibima.eu\/en\/estudio-prospectivo-de-24-meses-multicentrico-no-intervencional-para-evaluar-la-efectividad-de-elocta-en-comparacion-con-productos-del-factor-convencional-en-el-tratamiento-profilactico-de-pacientes\/","og_site_name":"Ibima","article_published_time":"2025-07-30T08:48:54+00:00","author":"prodriguez","twitter_card":"summary_large_image","twitter_misc":{"Written by":"prodriguez"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ibima.eu\/estudio-prospectivo-de-24-meses-multicentrico-no-intervencional-para-evaluar-la-efectividad-de-elocta-en-comparacion-con-productos-del-factor-convencional-en-el-tratamiento-profilactico-de-pacientes\/#article","isPartOf":{"@id":"https:\/\/ibima.eu\/estudio-prospectivo-de-24-meses-multicentrico-no-intervencional-para-evaluar-la-efectividad-de-elocta-en-comparacion-con-productos-del-factor-convencional-en-el-tratamiento-profilactico-de-pacientes\/"},"author":{"name":"prodriguez","@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635"},"headline":"Estudio prospectivo de 24 meses, multic\u00e9ntrico, no intervencional para evaluar la efectividad de Elocta en comparaci\u00f3n con productos del factor convencional en el tratamiento profil\u00e1ctico de pacientes con hemofilia A. (Sobi.Elocta-002)","datePublished":"2025-07-30T08:48:54+00:00","mainEntityOfPage":{"@id":"https:\/\/ibima.eu\/estudio-prospectivo-de-24-meses-multicentrico-no-intervencional-para-evaluar-la-efectividad-de-elocta-en-comparacion-con-productos-del-factor-convencional-en-el-tratamiento-profilactico-de-pacientes\/"},"wordCount":50,"commentCount":0,"articleSection":["Ensayos Cl\u00ednicos","Ensayos Cl\u00ednicos - BE-03"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ibima.eu\/estudio-prospectivo-de-24-meses-multicentrico-no-intervencional-para-evaluar-la-efectividad-de-elocta-en-comparacion-con-productos-del-factor-convencional-en-el-tratamiento-profilactico-de-pacientes\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ibima.eu\/estudio-prospectivo-de-24-meses-multicentrico-no-intervencional-para-evaluar-la-efectividad-de-elocta-en-comparacion-con-productos-del-factor-convencional-en-el-tratamiento-profilactico-de-pacientes\/","url":"https:\/\/ibima.eu\/estudio-prospectivo-de-24-meses-multicentrico-no-intervencional-para-evaluar-la-efectividad-de-elocta-en-comparacion-con-productos-del-factor-convencional-en-el-tratamiento-profilactico-de-pacientes\/","name":"Estudio prospectivo de 24 meses, multic\u00e9ntrico, no intervencional para evaluar la efectividad de Elocta en comparaci\u00f3n con productos del factor convencional en el tratamiento profil\u00e1ctico de pacientes con hemofilia A. (Sobi.Elocta-002) - Ibima","isPartOf":{"@id":"https:\/\/ibima.eu\/es\/#website"},"datePublished":"2025-07-30T08:48:54+00:00","author":{"@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635"},"breadcrumb":{"@id":"https:\/\/ibima.eu\/estudio-prospectivo-de-24-meses-multicentrico-no-intervencional-para-evaluar-la-efectividad-de-elocta-en-comparacion-con-productos-del-factor-convencional-en-el-tratamiento-profilactico-de-pacientes\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ibima.eu\/estudio-prospectivo-de-24-meses-multicentrico-no-intervencional-para-evaluar-la-efectividad-de-elocta-en-comparacion-con-productos-del-factor-convencional-en-el-tratamiento-profilactico-de-pacientes\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ibima.eu\/estudio-prospectivo-de-24-meses-multicentrico-no-intervencional-para-evaluar-la-efectividad-de-elocta-en-comparacion-con-productos-del-factor-convencional-en-el-tratamiento-profilactico-de-pacientes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/ibima.eu\/es\/"},{"@type":"ListItem","position":2,"name":"Estudio prospectivo de 24 meses, multic\u00e9ntrico, no intervencional para evaluar la efectividad de Elocta en comparaci\u00f3n con productos del factor convencional en el tratamiento profil\u00e1ctico de pacientes con hemofilia A. (Sobi.Elocta-002)"}]},{"@type":"WebSite","@id":"https:\/\/ibima.eu\/es\/#website","url":"https:\/\/ibima.eu\/es\/","name":"Ibima","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ibima.eu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635","name":"prodriguez","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","caption":"prodriguez"},"sameAs":["https:\/\/ibima.eu"],"url":"https:\/\/ibima.eu\/en\/author\/prodriguez\/"}]}},"_links":{"self":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts\/32988","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/comments?post=32988"}],"version-history":[{"count":3,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts\/32988\/revisions"}],"predecessor-version":[{"id":56097,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts\/32988\/revisions\/56097"}],"wp:attachment":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/media?parent=32988"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/categories?post=32988"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/tags?post=32988"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}